Search results
...Awarded $4 Million CIRM Grant to Support Clinical Trial of Adult RPESC-RPE-4W Therapy for Dry...
Benzinga· 12 hours agoLuxa Biotechnology (LuxaBio), a joint venture between Y2 Solution Co. Ltd, Seoul, South Korea and the Neural Stem Cell Institute (NSCI) in Rensselaer, New York, today announced receipt of a $4 million grant from the
Stealth BioTherapeutics Announces Participation at Upcoming Ophthalmology Conferences
WKBN 27 Youngstown· 11 hours agoAt the OIS Retina Innovation Summit...
Story from Associated Retina Consultants: Local group helps macular degeneration patients cope with...
The Arizona Republic· 6 days agoAccording to the Centers for Disease Control and Prevention (CDC), nearly 20 million Americans over...
Cognition Therapeutics hits enrollment goal in DLB study By Investing.com
Investing.com· 2 days agoCognition Therapeutics, Inc. (NASDAQ: CGTX), a biopharmaceutical company focused on...
Ocular Therapeutix™ to Host Investor Day in New York City on Thursday, June 13, 2024 - Ocular...
Benzinga· 12 hours agoOCUL "Ocular", the "Company"))), a biopharmaceutical company committed to enhancing people's vision and quality of life through the development and commercialization of innovative therapies ...
Ocugen (OCGN) to Report Q1 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 5 days agoOcugen (OCGN) is expected to provide updates regarding the developmental program of its lead...
8 Benefits of Eating Healthy Fats
Eat This, Not That! via AOL· 1 day agoPhotos: Canva. Design: Eat This, Not That!When it comes to navigating the world of fats, it's important to remember that not all fats are created equal....
Oculis (NASDAQ:OCS) Price Target Cut to $28.00
ETF DAILY NEWS· 6 days agoOculis (NASDAQ:OCS – Get Free Report) had its price target dropped by research analysts at HC Wainwright from $29.00 to $28.00 in a research note issued to investors on Wednesday, Benzinga reports ...
Small Business - Cordele Dispatch | Cordele Dispatch
Cordele Dispatch· 2 days agoCognition Therapeutics, Inc. (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders, today announced that the company ...
SightMD Pennsylvania Expands Practice with Acquisition of James Lewis, MD
PRWeb· 3 days ago/PRNewswire-PRWeb/ -- SightMD Pennsylvania, a leading multi-specialty ophthalmology platform, is pleased to announce the acquisition of James Lewis, MD....
